Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

COVID-19 News - SARS-CoV-2 Nucleocapsid 203K/204R Mutations - Inflammatory Response  Jul 22, 2023  7 months, 1 week, 1 hour, 37 minutes ago

COVID-19 News: SARS-CoV-2 Nucleocapsid 203K/204R Mutations Contribute To Heightened Host Inflammatory And Cytokine Response

facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
COVID-19 News: SARS-CoV-2 Nucleocapsid 203K/204R Mutations Contribute To Heightened Host Inflammatory And Cytokine Response
COVID-19 News - SARS-CoV-2 Nucleocapsid 203K/204R Mutations - Inflammatory Response  Jul 22, 2023  7 months, 1 week, 1 hour, 37 minutes ago
COVID-19 News: In the twenty-first century, humanity has faced one of its greatest challenges in the form of the COVID-19 pandemic. Ever since the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in late 2019, the virus has wreaked havoc worldwide, causing millions of deaths and disrupting lives in unimaginable way as reported in various past COVID-19 News reports. As researchers scramble to comprehend the virus's behavior, a new study has recently shed light on an unexpected connection between certain mutations in the SARS-CoV-2 nucleocapsid (N) protein and heightened inflammatory responses in severe COVID-19 cases.

Hyper-expression of immune response genes including cytokines in KR-Patients. A Venn diagram shows the number of all up-regulated genes (adj p-value < 0.05) between KR-patients and RG-patients. B Violin plot shows log2 fold-change values of all significantly (adj p-value < 0.05) up-regulated genes in KR-patients. DE genes are highly up-regulated in KR-patients compared to RG-patients. p-values were calculated using unpaired two-tailed t-test, ****P =  < 0.0001. C Dot plot showing GO-enrichment analysis (top 30 GO-Biological Processes BP enriched pathways are shown) for significantly up-regulated genes in KR-patients (adj p-value < 0.05 and log2 fold-change ≥ 2). The FDR is based on nominal p-value from the hypergeometric test. Fold Enrichment corresponds to the percentage of genes in the pathway list, divided by the corresponding percentage in the background. GO term analysis was performed by ShinyGO (version 0.074). D Heatmap of significantly differentially expressed cytokine-related genes. KR-Patients (n = 39), RG-Patients (n = 39), and Healthy controls (n = 34). The sample names show COVID-19 disease status (Severe = ICU/Deceased, Mild = Not admitted to ICU, and Healthy)

The Enigma of COVID-19 Severity
The severity of COVID-19 is influenced by a complex interplay of factors, with excessive inflammatory responses being a crucial element. The so-called "cytokine storms," characterized by an overabundance of proinflammatory cytokines and chemokines, are associated with the most severe and fatal cases of the disease. While previous research focused mainly on spike protein mutations that impact transmission and vaccine immunity, scientists began exploring other regions of the virus that might play a role in pathogenesis.
Unraveling the Nucleocapsid KR Mutations
In a new study, researchers identified two adjacent mutations, R203K and G204R (together known as KR), within the nucleocapsid (N) protein of SARS-CoV-2. The nucleocapsid protein plays a crucial role in the virus's lifecycle. These mutations were found to be correlated with increased disease severity in COVID-19 patients. However, the link between these mutations and the host immune response remained shrouded in mystery.
g>Diving into the Research
To understand the connection between the nucleocapsid KR mutations and the immune response, study team conducted a meticulous analysis. They divided COVID-19 patients into two cohorts based on the presence or absence of the KR mutations and compared their nasopharyngeal transcriptomes. The results were striking. The KR patients exhibited significantly elevated expression of proinflammatory cytokines, chemokines, and interferon-stimulated genes (ISGs) when compared to the RG patients (those with the wild-type N protein). Moreover, they found higher levels of neutrophils and the neutrophil-to-lymphocyte (NLR) ratio in the KR patients, further highlighting the connection between these mutations and inflammation.
Verifying the Findings
To confirm their observations, the study team employed a virus-like-particle (VLP) approach in cell culture models. The transcriptomic and proteomic profiling of VLP-incubated cells validated the link between the KR variant and a hyper-inflammatory immune response.
Unlocking the Mechanism
The exact molecular mechanism underlying the KR mutations' ability to trigger exacerbated immune responses is not yet fully understood. These mutations are located within a conserved serine-arginine (SR) rich linker region (LKR) critical for phosphorylation-dependent regulation of the N protein. The specific changes caused by the KR mutations might lead to heightened immune responses.
Additionally, the KR variant's increased interaction with various host proteins associated with signaling pathways and viral processes might also play a role. Further investigations are needed to unravel the intricacies of this connection.
Implications for COVID-19 Management
These study findings hold significant implications for understanding SARS-CoV-2 pathogenesis and developing more effective therapeutics and vaccines. By comprehending how these mutations modulate host immune responses, researchers can potentially design treatments that target specific inflammatory pathways. This knowledge may also aid in developing vaccines with broader protection against emerging SARS-CoV-2 variants and future coronaviruses.
The discovery of the link between SARS-CoV-2 nucleocapsid KR mutations and hyper-inflammatory immune responses provides a critical piece in the puzzle of COVID-19 severity. Unraveling the intricacies of this relationship opens new avenues for therapeutic interventions, helping us combat the devastating impact of the virus and emerge stronger in the face of future pandemics.
The study findings were published in the peer reviewed journal: Genome Medicine.
For the latest COVID-19 News, keep on logging to Thailand Medical News


Jun 10, 2023  9 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19